Skip to main Content

BNB Plus Corp. is building an operating company focused on AI, Web3, and distributed infrastructure for intelligent finance and emerging digital systems.
Its subsidiary, LineaRx, plans to bring that same infrastructure to biomanufacturing, pairing its proprietary cell-free DNA and mRNA production technologies with AI and distributed infrastructure to accelerate the manufacture of next-generation nucleic acid therapies.

Nasdaq (BNBX)